Robert S. Mannel

Obstetrics and Gynecology

800 NE 10th St Ste 2100
Oklahoma City, OK 73104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 94 publications

A vision transformer-radiomics approach for enhanced chemotherapy outcome prediction in ovarian cancer.

A vision transformer-radiomics approach for enhanced chemotherapy outcome prediction in ovarian cancer.

Journal: Frontiers in radiology

Published: September 10, 2025

Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocol.

Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocol.

Journal: Gynecologic oncology

Published: August 04, 2025

Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovary.

Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovary.

Journal: Gynecologic oncology

Published: July 11, 2025

Parameter efficient fine-tunning of foundation model to facilitate tumor response prediction for ovarian cancer patients.

Parameter efficient fine-tunning of foundation model to facilitate tumor response prediction for ovarian cancer patients.

Journal: BMC medical imaging

Published: June 26, 2025

Expanding the workforce of clinical trial investigators committed to gynecologic cancer research: the GOG Foundation, Inc's Scholar Career Development Award and New Investigator Program.

Expanding the workforce of clinical trial investigators committed to gynecologic cancer research: the GOG Foundation, Inc's Scholar Career Development Award and New Investigator Program.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: June 08, 2025

Randomized phase III trial of adjuvant radiation versus chemoradiation in intermediate-risk, early-stage cervical cancer following radical hysterectomy and lymphadenectomy: results from NRG Oncology/GOG-263/KGOG 1008.

Randomized phase III trial of adjuvant radiation versus chemoradiation in intermediate-risk, early-stage cervical cancer following radical hysterectomy and lymphadenectomy: results from NRG Oncology/GOG-263/KGOG 1008.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: June 05, 2025

Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancer.

Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancer.

Journal: Brachytherapy

Published: April 04, 2025

Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancer.

Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancer.

Journal: Brachytherapy

Published: April 04, 2025

Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial.

Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial.

Journal: Nature medicine

Published: September 23, 2024

Correlative Science in the Cooperative Group System: Re-Engineering for Success.

Correlative Science in the Cooperative Group System: Re-Engineering for Success.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 17, 2024

Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study.

Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 22, 2024

Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial.

Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 25, 2024

Showing 1-12 of 94

Last Updated: 09/26/2026